| 摘要 |
<p>A method of predicting the onset or severity of pulmonary fat embolism disorder in a patient, which comprises analyzing a body fluid of the patient for secretory phospholipase A2 concentration or activity; comparing the concentration or activity with a standard value selected from the group consisting of (1) a range of secretory phospholipase A2 concentrations or activities, respectively, for said body fluid in a control population and (2) a range of secretory phospholipase A2 concentrations or activities, respectively, of previously isolated samples of the body fluid of the patient; and relating a statistically significant higher concentration or activity, respectively, of secretory phospholipase A2 relative to the standard value as predictive of onset and severity of pulmonary fat embolism.</p> |
